Aminolevulinic Acid Hydrochloride

CHEMBL1200582 Phase 4 Одобрено Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
167.6 g/mol
LogP
Phase
4

The hydrochloride salt form of aminolevulinic acid, used as a photosensitizer in photodynamic therapy for superficial skin cancers and precancerous lesions, and as a fluorescent marker to help surgeons identify and remove malignant tissue during cancer operations.

Молекулярная масса

167,5900 g/mol

TPSA

80,40 Ų

Терапевтические области

Механизм действия

Accumulates in target tissues and generates reactive oxygen species upon activation by specific wavelengths of light, causing localized cellular damage and destruction of pathological tissue.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Механизм

Accumulates in target tissues and generates reactive oxygen species upon activation by specific wavelengths of light, causing localized cellular damage and destruction of pathological tissue.

2D Структура

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cl.NCC(=O)CCC(=O)O

InChI

InChI=1S/C5H9NO3.ClH/c6-3-4(7)1-2-5(8)9;/h1-3,6H2,(H,8,9);1H

Molecular Formula

C5H10ClNO3

HBD / HBA

3 / 4

Вращаемые Связи

4

Тяжёлые Атомы

10

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Часто задаваемые вопросы

The hydrochloride salt form of aminolevulinic acid, used as a photosensitizer in photodynamic therapy for superficial skin cancers and precancerous lesions, and as a fluorescent marker to help surgeons identify and remove malignant tissue during cancer operations.

Accumulates in target tissues and generates reactive oxygen species upon activation by specific wavelengths of light, causing localized cellular damage and destruction of pathological tissue.

Yes, Aminolevulinic Acid Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200582. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 123608. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Медицинский отказ от ответственности

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.